1 Followers HKEX:1672 - Ascletis Pharma Inc Ascletis Pharma Inc
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
Add Alert 

Yahoo Finance

HKD 2.75    -0.010 (-0.36%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

24 Sep 2021



CEO: Dr. Jinzi Jason Wu

Headquarters: HK

Employees: 238



Ascletis Pharma Inc is a research and development driven biotechnology company which provides medical solutions in the field of antiviral, cancer, and fatty liver diseases. The products in the pipeline include HCV, HBV, ASC09, and ASC06. It currently has five anti-viral drug discovery and development programs, including two HCV drug candidates near commercial-stage and one HIV drug candidate that has completed a phase IIa clinical trial. Geographically, it operates in Mainland China and other countries.